MLH1 methylation screening is effective in identifying epimutation carriers
暂无分享,去创建一个
S. Gruber | C. Lázaro | G. Capellá | J. Brunet | I. Blanco | M. Navarro | O. Campos | M. Pineda | M. Iniesta | P. Mur | E. Borrás | G. Vargas | Sílvia Iglesias | Anna Fernández | Olga Campos
[1] S. Gruber,et al. MLH1 promoter hypermethylation in the analytical algorithm of Lynch syndrome: a cost-effectiveness study , 2012, European Journal of Human Genetics.
[2] M. Crépin,et al. Evidence of constitutional MLH1 epimutation associated to transgenerational inheritance of cancer susceptibility , 2012, Human mutation.
[3] C. Kwok,et al. Identification of new cases of early‐onset colorectal cancer with an MLH1 epimutation in an ethnically diverse South African cohort † , 2011, Clinical genetics.
[4] R. Ward,et al. Dominantly inherited constitutional epigenetic silencing of MLH1 in a cancer-affected family is linked to a single nucleotide variant within the 5'UTR. , 2011, Cancer cell.
[5] P. Broderick,et al. MLH1-93G > A is a risk factor for MSI colorectal cancer. , 2011, Carcinogenesis.
[6] M. Kloor,et al. Biallelic MLH1 SNP cDNA expression or constitutional promoter methylation can hide genomic rearrangements causing Lynch syndrome , 2011, Journal of Medical Genetics.
[7] Julie O. Culver,et al. Recurrence and variability of germline EPCAM deletions in Lynch syndrome , 2011, Human mutation.
[8] Z. Herceg,et al. Intensity‐dependent constitutional MLH1 promoter methylation leads to early onset of colorectal cancer by affecting both alleles , 2011, Genes, chromosomes & cancer.
[9] B. Bapat,et al. Functional effects of the MLH1-93G>A polymorphism on MLH1/EPM2AIP1 promoter activity. , 2011, Oncology reports.
[10] C. Boland,et al. De novo constitutional MLH1 epimutations confer early‐onset colorectal cancer in two new sporadic Lynch syndrome cases, with derivation of the epimutation on the paternal allele in one , 2011, International journal of cancer.
[11] A. Paterson,et al. Specific Variants in the MLH1 Gene Region May Drive DNA Methylation, Loss of Protein Expression, and MSI-H Colorectal Cancer , 2010, PloS one.
[12] N. Rosenberg,et al. MLH1 founder mutations with moderate penetrance in Spanish Lynch syndrome families. , 2010, Cancer research.
[13] M. Esteller,et al. Novel methylation panel for the early detection of colorectal tumors in stool DNA. , 2010, Clinical colorectal cancer.
[14] Antoni Castells,et al. Methylation analysis of MLH1 improves the selection of patients for genetic testing in Lynch syndrome. , 2010, The Journal of molecular diagnostics : JMD.
[15] L. Hesson,et al. Epimutations and cancer predisposition: importance and mechanisms. , 2010, Current opinion in genetics & development.
[16] H. Morreau,et al. Early onset MSI-H colon cancer with MLH1 promoter methylation, is there a genetic predisposition? , 2010, BMC Cancer.
[17] Richard D Kolodner,et al. Comprehensive molecular analysis of mismatch repair gene defects in suspected Lynch syndrome (hereditary nonpolyposis colorectal cancer) cases. , 2009, Cancer research.
[18] R. Ward,et al. Constitutional (germline) MLH1 epimutation as an aetiological mechanism for hereditary non-polyposis colorectal cancer , 2009, Journal of Medical Genetics.
[19] M. Ridanpää,et al. Large genomic rearrangements and germline epimutations in Lynch syndrome , 2009, International journal of cancer.
[20] D. Bishop,et al. MLH1 −93G>A promoter polymorphism and risk of mismatch repair deficient colorectal cancer , 2008, International journal of cancer.
[21] M. Ebert,et al. Further evidence for heritability of an epimutation in one of 12 cases with MLH1 promoter methylation in blood cells clinically displaying HNPCC , 2008, European Journal of Human Genetics.
[22] C. Ulrich,et al. Mismatch repair polymorphisms and risk of colon cancer, tumour microsatellite instability and interactions with lifestyle factors , 2008, Gut.
[23] R. Ward,et al. Erasure of MLH1 methylation in spermatozoa—implications for epigenetic inheritance , 2007, Nature Genetics.
[24] P. Goodfellow,et al. Evidence for heritable predisposition to epigenetic silencing of MLH1 , 2007, International journal of cancer.
[25] P. Møller,et al. Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer) , 2007, Journal of Medical Genetics.
[26] David I. K. Martin,et al. Inheritance of a cancer-associated MLH1 germ-line epimutation. , 2007, The New England journal of medicine.
[27] M. Urioste,et al. MLH1 germline epimutations in selected patients with early‐onset non‐polyposis colorectal cancer , 2007, Clinical genetics.
[28] Megan Hitchins,et al. MLH1 germline epimutations as a factor in hereditary nonpolyposis colorectal cancer. , 2005, Gastroenterology.
[29] P. Peltomäki,et al. Mutations Associated with HNPCC Predisposition — Update of ICG-HNPCC/INSiGHT Mutation Database , 2004, Disease markers.
[30] Teruhiko Yoshida,et al. Extensive but hemiallelic methylation of the hMLH1 promoter region in early-onset sporadic colon cancers with microsatellite instability. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[31] M. Loda,et al. A hereditary nonpolyposis colorectal carcinoma case associated with hypermethylation of the MLH1 gene in normal tissue and loss of heterozygosity of the unmethylated allele in the resulting microsatellite instability-high tumor. , 2002, Cancer research.
[32] G. Deng,et al. Methylation of hMLH1 promoter correlates with the gene silencing with a region-specific manner in colorectal cancer , 2002, British Journal of Cancer.
[33] C. Boland,et al. Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives. , 1995, Journal of the National Cancer Institute.
[34] H. Cann,et al. Centre d'etude du polymorphisme humain (CEPH): collaborative genetic mapping of the human genome. , 1990, Genomics.
[35] R. Ward,et al. Constitutional (germline) MLH1 epimutation as an aetiological mechanism for hereditary non-polyposis colorectal cancer , 2009, Journal of Medical Genetics.
[36] Suet Yi Leung,et al. Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1 , 2009, Nature Genetics.
[37] H. Lynch,et al. Hereditary colorectal cancer syndromes: molecular genetics, genetic counseling, diagnosis and management , 2007, Familial Cancer.
[38] David I. K. Martin,et al. Germline epimutation of MLH1 in individuals with multiple cancers , 2004, Nature Genetics.
[39] B. Bapat,et al. Functional effects of the MLH 193 G > A polymorphism on MLH 1 / EPM 2 AIP 1 promoter activity , 2022 .